Lisa Samson-Fang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lisa Samson-Fang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Charlene Butler
1 shared publicationChuck Norlin
1 shared publicationJudith Gooch
1 shared publication- Kristie L. Bell
Queensland Cerebral Palsy and Rehabilitation Research Centre, Children’s Nutrition Research Centre, Queensland Children’s Medical Research Institute, The University of Queensland, Brisbane, Queensland, Australia
1 shared publication Maureen O'Donnell
1 shared publication
Latest Publications
- Open Access
- 4 December 2013
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 67 (S2) , S5-S8
Assessment of growth and nutrition in children with cerebral palsy
This manuscript provides an update on the assessment of growth and nutrition in children with cerebral palsy and children with similar neurodevelopmental disabilities. Topics include the assessment of linear growth using segmental measures, avoidance of commonly used tools to assess nutritional status in typically developing children that are not valid in this population of children and how to use other nutritional assessment tools that have been developed specific to this population of children.
- 4 December 2013
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 67 (S2) , S5-S8
Open AccessAssessment of growth and nutrition in children with cerebral palsy
This manuscript provides an update on the assessment of growth and nutrition in children with cerebral palsy and children with similar neurodevelopmental disabilities. Topics include the assessment of linear growth using segmental measures, avoidance of commonly used tools to assess nutritional status in typically developing children that are not valid in this population of children and how to use other nutritional assessment tools that have been developed specific to this population of children.
- 25 October 2011
- Published by Springer Nature
- p. 1829-1840
Growth in Osteogenesis Imperfecta
- 9 May 2003
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 45 (06) , 415-26
Effects of gastrostomy feeding in children with cerebral palsy: an AACPDM evidence report
- 9 May 2003
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 45 (06) , 415-26
Effects of gastrostomy feeding in children with cerebral palsy: an AACPDM evidence report
- 1 August 2000
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 42 (8) , 561-565
Intrathecal baclofen withdrawal simulating neuroleptic malignant syndrome in a child with cerebral palsy
Intrathecal baclofen infusion (IBI) is being used with increasing frequency in children to treat spasticity and dystonia. In this report, we summarize the clinical course of a 9-year-old boy with quadriplegic cerebral palsy with mixed tonal abnormalities (spasticity and dystonia) experiencing withdrawal from intrathecal baclofen. His clinical course is compared to that of adults experiencing withdrawal from IBI and to neuroleptic malignant syndrome. If unrecognized, this disorder may have significant potential for morbidity and mortality. Clues to diagnosis, appropriate evaluation, and potential treatments are discussed. When a child treated with IBI presents with unexplained multiorgan system dysfunction, particularly if accompanied by evidence of rhabdomyolysis, the integrity of the IBI system must be evaluated. In some cases, evaluation might necessitate surgical exploration. Caregivers most commonly seek urgent evaluation and treatment from their primary care provider when their child experiences fever or acute illness. Primary care providers of children treated with IBI should be made aware of this clinical scenario to prevent delays in diagnosis.
- 1 August 2000
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 42 (8) , 561-565
Intrathecal baclofen withdrawal simulating neuroleptic malignant syndrome in a child with cerebral palsy
Intrathecal baclofen infusion (IBI) is being used with increasing frequency in children to treat spasticity and dystonia. In this report, we summarize the clinical course of a 9-year-old boy with quadriplegic cerebral palsy with mixed tonal abnormalities (spasticity and dystonia) experiencing withdrawal from intrathecal baclofen. His clinical course is compared to that of adults experiencing withdrawal from IBI and to neuroleptic malignant syndrome. If unrecognized, this disorder may have significant potential for morbidity and mortality. Clues to diagnosis, appropriate evaluation, and potential treatments are discussed. When a child treated with IBI presents with unexplained multiorgan system dysfunction, particularly if accompanied by evidence of rhabdomyolysis, the integrity of the IBI system must be evaluated. In some cases, evaluation might necessitate surgical exploration. Caregivers most commonly seek urgent evaluation and treatment from their primary care provider when their child experiences fever or acute illness. Primary care providers of children treated with IBI should be made aware of this clinical scenario to prevent delays in diagnosis.